GlassScriptPhysician profile
Carla Coffey
NPI 1699204115
$831.68
in general payments reported to CMS, 2019-2025
15 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $320 · 2022: $97.75 · 2023: $84.54 · 2024: $162 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $261.75 | 2021-2024 | Tymlos |
| Amgen INC. | $113.28 | 2021-2024 | Prolia, Evenity |
| Convatec INC. | $92.66 | 2021-2023 | |
| Vertex Pharmaceuticals Incorporated | $71.04 | 2024-2025 | |
| Revance Therapeutics, INC. | $60.35 | 2024-2025 | Daxxify |
| Boston Scientific Corporation | $42.26 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $38.46 | 2025 | Zilretta |
| Fidia Pharma USA INC. | $29.13 | 2022 | |
| Heron Therapeutics, INC. | $21.82 | 2021 | |
| Djo, LLC | $19.46 | 2025 | Cmf |
| Hartmann USA, INC. | $18.51 | 2025 | Zetuvit Plus 10x10 P10 |
| Ucb, INC. | $18.22 | 2022 | |
| Alexion Pharmaceuticals, INC. | $15.87 | 2023 | Strensiq |
| Integra Lifesciences Corporation | $14.66 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Orthofix Medical, INC. | $14.21 | 2024 | Physio-Stim, Accelstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Coffey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.